Zenith Epigenetics Announces a Publication Highlighting the Role of ZEN-3694 in Overcoming Resistance to Therapies in Metastatic Castration-Resistant Prostate Cancer
June 24, 2021 08:00 ET
|
Zenith Capital Corp.
CALGARY, Alberta, June 24, 2021 (GLOBE NEWSWIRE) -- Zenith Capital Corp. (“Zenith” or the “Company”), a clinical stage pharmaceutical company focused on the development of novel epigenetic...
Zenith Epigenetics Announces Clinical Collaboration with Astellas
April 22, 2021 08:00 ET
|
Zenith Capital Corp.
CALGARY, Alberta, April 22, 2021 (GLOBE NEWSWIRE) -- Zenith Epigenetics Ltd. (“Zenith” or the “Company”), a clinical stage biotechnology company focused on the development of novel epigenetic...
Zenith Epigenetics Announces Dosing of First mCRPC Patient with a Combination of ZEN-3694 + Merck’s Immune Check Point Inhibitor KEYTRUDA
March 15, 2021 08:00 ET
|
Zenith Capital Corp.
CALGARY, Alberta, March 15, 2021 (GLOBE NEWSWIRE) -- Zenith Epigenetics Ltd. (“Zenith” or the “Company”) announced today the dosing of first patient with a triple combination of ZEN-3694 + Merck’s...
Zenith Announces Voting Results from the 2020 Annual and Special Meeting of Shareholders
December 22, 2020 17:14 ET
|
Zenith Capital Corp.
CALGARY, Alberta, Dec. 22, 2020 (GLOBE NEWSWIRE) -- Zenith Capital Corp. ("Zenith" or the "Company") announces that, at its annual and special meeting of shareholders held earlier today, Zenith...
Zenith Files Notice of Annual and Special Meeting of Shareholders
November 20, 2020 18:27 ET
|
Zenith Capital Corp.
CALGARY, Alberta, Nov. 20, 2020 (GLOBE NEWSWIRE) -- Zenith Capital Corp. (“Zenith” or the “Company”) today announces the filing on SEDAR (www.sedar.com) of the Notice of Meeting and Management...
Zenith Confirms Interim Filings on SEDAR
October 28, 2020 10:10 ET
|
Zenith Capital Corp.
CALGARY, Alberta, Oct. 28, 2020 (GLOBE NEWSWIRE) -- Zenith Capital Corp. (“Zenith” or the “Company”) today announces that, further to its October 9, 2020 press release, it today has filed its...
Zenith Provides Update Regarding Extension of its Filing Calendar
October 09, 2020 19:57 ET
|
Zenith Capital Corp.
CALGARY, Alberta, Oct. 09, 2020 (GLOBE NEWSWIRE) -- Zenith Capital Corp. (“Zenith” or the “Company”) today announces that it has filed its annual financial statements for the year ended April 30,...
Zenith Epigenetics Announces Collaboration with NCI in Developing ZEN-3694 for Multiple Oncology Indications
October 05, 2020 08:00 ET
|
Zenith Capital Corp.
CALGARY, Alberta, Oct. 05, 2020 (GLOBE NEWSWIRE) -- Zenith Epigenetics Ltd. (“Zenith” or the “Company”) announced today the execution of a cooperative research and development agreement (CRADA) with...
Zenith Provides Update Regarding Extension of its Filing Calendar
October 01, 2020 19:00 ET
|
Zenith Capital Corp.
CALGARY, Alberta, Oct. 01, 2020 (GLOBE NEWSWIRE) -- Zenith Capital Corp. (“Zenith” or the “Company”) today announces that, further to its September 17, 2020 press release, it continues to expect to...
Zenith Provides Update Regarding Extension of its Filing Calendar
September 17, 2020 19:00 ET
|
Zenith Capital Corp.
CALGARY, Alberta, Sept. 17, 2020 (GLOBE NEWSWIRE) -- Zenith Capital Corp. (“Zenith” or the “Company”) today announces that, further to its August 26, 2020 press release, it continues to rely on...